Drug intelligence / Profile preview

Relicann

Development stage
Unknown
Lead developer
Revive Therapeutics
Modality
Small Molecules
Administration
Oral, Transmucosal
01

Overview

**Relicann** is a proprietary hemp-based cannabidiol product brand from Revive Therapeutics, with the specifically described product being a controlled-release chewing gum formulation that contains hemp oil and cannabidiol for the health and wellness and medical cannabis market. Publicly available company materials describe it as a cannabinoid delivery product rather than an approved prescription pharmaceutical, using oral mucosal delivery through chewing gum to improve cannabinoid absorption and bioavailability. The explicitly identifiable active drug substance is cannabidiol derived from hemp; however, Relicann appears to function primarily as a brand/platform name for a cannabinoid wellness product line rather than a clearly defined approved drug with a well-established clinical indication or regulatory approval as a pharmaceutical.

Brand names
Relicann
Other names
RELICANNRelicann hemp-based CBD gumRelicann hemp-based cannabidiol chewing gum

Beyond the preview

Go deeper on Relicann.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Relicann.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call